1 / 31

ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for noncardiac surgery

ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for noncardiac surgery. Dr. Sonia Anand McMaster University. Overview. Guidelines- reflect evidence synthesis and consensus Evidence as of October 2007 Important Decision points: Urgent vs Elective Surgery

Jims
Download Presentation

ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for noncardiac surgery

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for noncardiac surgery Dr. Sonia Anand McMaster University

  2. Overview • Guidelines- reflect evidence synthesis and consensus • Evidence as of October 2007 • Important Decision points: • Urgent vs Elective Surgery • High risk surgery vs intermediate vs low • Active Cardiac Condition vs non-active

  3. The Search For High Risk

  4. Methods for Assessing Risk Pre-Operatively Patient Based • High risk conditions • Functional Capacity Surgery Based • Vascular Surgery • Emergency surgery Intervention Based • Medications • Revascularization

  5. Six Independent predictors of cardiac risk • ischemic heart disease • congestive heart failure 3) cerebrovascular disease 4) high risk surgery (AAA, orthopedic sx) 5) pre-operative insulin tx for diabetes 6) preoperative creatinine for creat > 2 mg/dL Lee et al

  6. Active/Major Cardiac Conditions • Unstable Coronary Conditions • Decompensated CHF • Significant arrhythmias (i.e. 3⁰HB, new Vtach) • Severe Valvular Disease (aortic stenosis >40 mm hg gradient or valve area <1.0cm₂)???????

  7. Non-Active Cardiac Factors • Intermediate Risk • Hx of CHD • History of prior CHF • Hx of stroke • Diabetes • Renal insufficiency • Minor Risk* • Age > 70 • Abnormal ECG • Nonsinus rhythm • Uncontrolled systolic BP * Not associated with cardiac risk

  8. Functional Capacity • Functional status has shown to be a reliable periop and long-term predictor of cardiac events • Functional status determined based on ability to do ADL’s • MET: metabolic equivalent resting oxygen consumption of 70 kg, 40 yr old man at rest • Periop risk is increased if person cannot > 4 METS

  9. Moderate recreational golf, dancing, baseball Strenuous sports swimming, basketball DO light house work i.e. Washing dishes Climb a flight of stairs Run a short distances Eat, dress 10 MET 1 MET 4 MET

  10. The Trump Card: Functional Capacity • Perioperative cardiac risk is increased in patients unable to exercise 4 METs • Functional capacity can be estimated in the office • Energy expenditure for eating, dressing, walking around house, dishwashing ranges from 1-4 METs • Climbing a flight of stairs, running a short distance, scrubbing floors, and golf ranges from 4-10 METs • Swimming and singles tennis exceeds 10 METs

  11. Surgery Risk Type

  12. Surgery-Specific Risk: High Risk* • Major emergency surgery • Vascular surgery including: aortic surgery, infra-inguinal bypass • Prolonged surgery with large fluid shifts or blood loss * Reported risk of cardiac death or nonfatal MI >5%

  13. Stepwise Approach • Step 1: Determine urgency of surgery • Step 2: Active cardiac condition?-→test • Step 3: Undergoing low-risk surgery? < 1%* • Step 4: Good functional capacity? *Combined morbidity and mortality < 1% even in high risk patients

  14. The Catheterization Questions to Ask Yourself • Does this patient have symptomatic coronary disease that will have a mortality benefit from revascularization now? • Am I willing to send the patient to CABG? • Am I doing this just to know the anatomy?

  15. Is pre-op coronary revasc advantageous? • If high risk surgery and patient has active cardiac issue • Functional test and perfusion Imaging and if • L main 50% or 3 VD, 2VD + LAD Prox, LVEF < 20%, aortic stenosis – consider revasc pre-op • CARP – if none of these – no advantage of revasc

  16. Functional Test • Exercise test with ECG • If abnormal ECG, Rx perfusion imaging • Adenosine • Dipyridamole • Dobutamine • Dobutamine stress echo

  17. *** 10 (n=314) 8.5 Periop MI 8 Death 6 * 4 3.0 2.8 * *** 2 1.1 0.6 0 0 No CAD CAD: Medical Rx CAD: CABG Effect of Prior CABG on Cardiac Risk of Vascular Surgery: The CASS Registry Eagle et al. Circulation, 1997

  18. Coronary Revascularization Does Not Improve Immediate or Long-Term Outcomes 510 VA pts, aged 66 years, with stable CAD, scheduled for elective AAA repair (33%) or infrainguinal bypass (67%), randomized to Revasc (PCI 59%, CABG 41%) or conservative management. 25 20 15 10 5 0 Post-Op MI 30 Day 2.7 Year Mortality Mortality Revascularization Conservative Mgmt McFalls, E. CARP Trial;AHA 2004

  19. High Risk Patients & Revascularization Pre-Op 101 pts with extensive ischemia randomly assigned to pre-op revascularization or not. Endpoints: all-cause death or MI at 30 days and 1-year follow-up. 50 40 30 % 20 2VD in 12 (24%), 3VD in 33 (67%), Left main in 4 (8%). 10 0 7 14 21 28 0 3 6 9 12 Days since surgery Months since surgery Poldermans, D. JACC 2007; 49(17): 1763

  20. 1.0 0.9 0.8 Survival Free of Death/MI 0.7 0.6 0.5 7 0 1 2 3 4 5 6 Years The Effect of Percutaneous Revascularization Above Optimal Medical Therapy:COURAGE 2287 Pts w/myocardial ischemia and CAD randomized to PCI with optimal medical therapy (PCI group) and 1138 to medical therapy alone. Medical therapy PCI + Medical therapy Boden, W. NEJM 2007; 356:1503

  21. STENTS If upcoming Sx is known then PTCA alone or BMS with 4-6 wks dual antiplatelet tx after If received DES.... • 1) postpone sx until > 12 months, • 2) do sx on both asa+clop • 3) do sx on single ap tx

  22. Use of a DES for coronary revascularization before imminent or planned non cardiac sx that will necessitate d/c of antiplatelet agents is not recommended

  23. Medical tx 1) beta blockers-if on keep them if not.... 2) Statins continue, ? Start -need randomized trials

  24. Statins Improve Survival After Vascular Surgery 100 pts randomized 20 mg atorvastatin or placebo for 45 days. Vascular surgery ~ 30 days after randomization. F/U 6 months Primary Endpoint CV death + NFMI+ Ischemic stroke+ Unstable Angina Durazzo, AES. JVS 2004:39(5):975

  25. 1.00 .75 Survival .50 .25 0 0 60 20 40 80 100 Time (months) Statins Improve Long-Term Survival After Vascular Surgery Retrospective review of 446 consecutive infrainguinal bypass surgeries Statin (+) p < 0.004 Statin (-) Ward, RP. Int J Card 2005; 104(3):264

  26. Other Issues • DVT/PE prophylaxis • Anesthetic technique-volatile agent with general anesthetic - ↓ troponin ↑ LV function >> propofol, midazolam, balanced anesthesia (Grade B) • No evidence that epidural anesthesia >>general anesthesia for cardiac outcomes • Routine troponin monitoring not recommended

  27. Surveillance for Perioperative Myocardial Infarction • ECGs • All intermediate and high-risk patients should get a post-op ECG. • As need for signs or symptoms of ischemia • Troponin / CK • In patients with signs or symptoms of ischemia • Do not do screening biomarkers

  28. High Risk Features • Severe obstructive or restrictive pulmonary disease • Diabetes • Renal impairment • Anemia, polycythemia, thrombocytosis

  29. PCI pre-op • ST-elevation MI • Unstable angina • Non ST elevation MI

  30. 2007 ACC/AHA Perioperative Guidelines

  31. Take Home Messages • Unstable syndromes require management prior to surgery. Look for • Unstable angina • Signs of heart failure • Stenotic valve lesions • Ventricular arrhythmias • Functional tolerance is the best single predictor of outcome • Be very specific in your history (one step at at time, regular or slow pace, etc) • If patient on beta blockers & statins continue them, more trials to mandate them • PCI/CABG only if patient needs it independent of surgery. Think twice because of stent data and delays.

More Related